CEA with HAMA Treatment

The CEA with HAMA Treatment test contains 1 test with 1 biomarker.

CEA is a tumor marker that is useful to monitor patients with persistent, recurrent or metastatic colonic carcinoma. Patients who have received mouse monoclonal antibodies as part of treatment should have their specimens pre-treated for removal of the human antimouse antibodies (HAMA).

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Cea, Hama Treated